Growth through expansion ECLAT has recent and planned global expansion, including a major 800-seat facility in Hyderabad, India, signaling ongoing capacity growth and a need for scalable back-office support, IT, and nearshore delivery partnerships to sustain international operations.

AI driven offerings The launch of a full suite of AI-powered risk adjustment and quality solutions at RISE National 2026 indicates a strategic push into advanced analytics and automation, presenting opportunities to upsell AI-enabled coding, denial management, and quality reporting services.

Revenue Cycle focus Specialization in medical coding and revenue cycle consulting positions ECLAT as a partner for hospitals and physician practices aiming to improve reimbursement timeliness and accuracy, suggesting cross-sell of end-to-end RCM, audits, and HIPAA compliance solutions.

Strategic acquisitions Recent asset acquisition of Excite Health Partners’ assets for 7M signals a consolidation phase and potential uptick in integrated HIM and coding capabilities, offering opportunities for bundled services and expanded client penetration.

Scale and targeting With a workforce of 1001-5000 and a mid-tier revenue range, ECLAT sits between smaller niche players and large enterprise vendors, making it suitable for mid-market healthcare systems and large groups seeking cost-effective, compliant delivery with global reach.